Patents Assigned to Eisai Co., Limited
  • Modifying the permeability of physiological barriers
    Publication number: 20020142943
    Abstract: The degree of phosphorylation of serine and threonine residues of p100/p120 can affect the permeability of physiological barriers and also cell-cell adhesion properties. By changing physiological levels, various disorders can be treated, including multiple sclerosis, cancer, head injuries, oedema, stroke, inflammation and gastric ulcers. Furthermore, drugs can be allowed to pass across physiological barriers and the barriers can then be closed.
    Type: Application
    Filed: May 24, 2002
    Publication date: October 3, 2002
    Applicant: Eisai Co., Limited
    Inventors: James Martin Staddon, Mary Louise Morgan, Marianne Jennifer Ratcliffe
  • Modifying the permeability of physiological barriers
    Patent number: 6407058
    Abstract: The degree of phosphorylation of serine and threonine residues of p100/p120 can affect the permeability of physiological barriers and also cell—cell adhesion properties. By changing physiological levels, various disorders can be treated, including multiple sclerosis, cancer, head injuries, oedema, stroke, inflammation and gastric ulcers. Furthermore, drugs can be allowed to pass across physiological barriers and the barriers can then be closed.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: June 18, 2002
    Assignee: Eisai Co., Limited
    Inventors: James Martin Staddon, Mary Louise Morgan, Marianne Jennifer Ratcliffe